Why the study?
Does transvenous cardioversion compared to rapid ventricular pacing improve the termination of induced ventricular tachycardia in patients with spontaneous ventricular tachycardia and organic heart disease?
Does transvenous cardioversion compared to rapid ventricular pacing improve the termination of induced ventricular tachycardia in patients with spontaneous ventricular tachycardia and organic heart disease?
Transvenous cardioversion and rapid ventricular pacing have comparable efficacy for terminating induced ventricular tachycardia, but cardioversion is associated with more frequent transient supraventricular tachyarrhythmias and patient discomfort.
Answers are grounded in this paper and cite their sources.
Rapid ventricular pacing may be preferred to minimize discomfort and arrhythmias; challenges routine transvenous cardioversion despite comparable efficacy in induced VT.
We performed a prospective, randomized crossover study to evaluate the comparative efficacy of transvenous cardioversion and rapid ventricular pacing for termination of induced ventricular tachycardia in patients with spontaneous ventricular tachycardia and organic heart disease. Sixty-two episodes of ventricular tachycardia were induced in 15 patients, mean age 60 +/- 10 years, during electrophysiologic studies. All patients underwent a preselected electrical therapy protocol in a randomized crossover sequence. Transvenous cardioversion was performed by an incremental protocol of three sequential shocks (0.5, 1.1, and 2.7 J). Six asynchronous sequential bursts of rapid ventricular pacing (10 and 15 paced stimuli at 90%, 75%, and 65% of ventricular tachycardia cycle length) were used. Mean cycle length of ventricular tachycardia for the study population was 391 +/- 85 msec. The morphology of the tachycardia was left bundle branch block in 27, right bundle branch block in 32, and indeterminate in three. Characteristics of ventricular tachycardia terminated by the two techniques were comparable. Rate of success for termination of tachycardia with the two methods was also comparable (transvenous cardioversion 83%, rapid ventricular pacing 80%; p greater than .1) and these responses were concordant in 78%. The modes of termination of ventricular tachycardia were similar. The incidence of acceleration of ventricular tachycardia per episode with these preselected protocols was also comparable (transvenous cardioversion 11%, rapid ventricular pacing 6%; p greater than .2). Transient supraventricular tachyarrhythmias were more frequent after transvenous cardioversion (23%) than after rapid ventricular pacing (3%). Significant patient discomfort occurred only after transvenous cardioversion (incidence of 57%).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Saksena et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: